Group One Trading
URGN icon

Group One Trading’s UroGen Pharma URGN Stock Holding History

Group One Trading’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Sell
3,046
-1,620
-35% -$43.9K ﹤0.01% 4763
2026
Q1 		$83.9K Buy
+4,666
New +$93.5K ﹤0.01% 4884
2025
Q2 		– Sell
-25,350
Closed -$243K – 8704
2025
Q1 		$280K Buy
25,350
+23,961
+1,725% +$255K ﹤0.01% 3670
2024
Q4 		$14.8K Sell
1,389
-6,385
-82% -$76.4K ﹤0.01% 5889
2024
Q3 		$98.7K Sell
7,774
-1,515
-16% -$22.5K ﹤0.01% 4189
2024
Q2 		$156K Buy
+9,289
New +$132K ﹤0.01% 3607
2024
Q1 		– Sell
-100
Closed -$1.64K – 8001
2023
Q4 		$1.5K Buy
+100
New +$1.3K ﹤0.01% 6900
2022
Q1 		– Sell
-14,036
Closed -$133K – 8758
2021
Q4 		$133K Sell
14,036
-29,592
-68% -$417K ﹤0.01% 5479
2021
Q3 		$734K Sell
43,628
-9,146
-17% -$145K ﹤0.01% 3758
2021
Q2 		$806K Sell
52,774
-35,825
-40% -$648K ﹤0.01% 3654
2021
Q1 		$1.73M Sell
88,599
-41,142
-32% -$873K ﹤0.01% 2630
2020
Q4 		$2.34M Sell
129,741
-25,169
-16% -$527K ﹤0.01% 1917
2020
Q3 		$2.99M Buy
154,910
+90,038
+139% +$2.04M 0.01% 1276
2020
Q2 		$1.69M Buy
64,872
+42,930
+196% +$1.05M 0.01% 1596
2020
Q1 		$391K Sell
21,942
-6,154
-22% -$166K ﹤0.01% 2226
2019
Q4 		$938K Buy
+28,096
New +$767K 0.01% 1944
2018
Q4 		– Sell
-180
Closed -$8.09K – 5441
2018
Q3 		$9K Buy
+180
New +$8.36K ﹤0.01% 4698

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Group One Trading's URGN Position: Q2 2026 in Review

Group One Trading reduced its UroGen Pharma (URGN) stake by 35% in Q2 2026, selling an estimated $43.9K and leaving 3,046 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #4763.

Group One Trading first reported a position in URGN in Q3 2018 and has held it in 17 quarters since. The position peaked at $2.99M in Q3 2020. 190 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Group One Trading held 3,046 shares of UroGen Pharma worth $112K as of Q2 2026.
  • Group One Trading sold 1,620 UroGen Pharma shares in Q2 2026, an estimated $43.9K.
  • UroGen Pharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4763 holding.
  • Group One Trading first reported a position in UroGen Pharma in Q3 2018 and has held it in 17 quarters since.
  • Group One Trading's UroGen Pharma position peaked at $2.99M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.